FDA Investigator Astrida B Mattson

Astrida B Mattson has conducted inspections on 108 sites in 1 countries as of 25 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
108
Last Inspection Date:
25 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100003147
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Astrida B Mattson:
Aaron J Poloni, Alan D Grupe, Alexander M Kay, Amy R Glynn, Andrew K Haack, PhD, Anita Narula, PhD, Annette L Diggs, Ashar P Parikh, Barbara J Rincon, Barbara Janine Breithaupt, Bradley Dworak, PhD, Brandon R Boone, Brenda K Alford, Brenda L Reihing, Bruce R Burrell, Carl A Anderson, Caryn M Mcnab, Catherine J Laufmann, Christian D Lynch (CDL), Christine A Harman, PhD, Clint R Van Blaricom, Connie P Rezendes, Crystal A Harlan, Cynthia J Lee, MS, David A Quale, David J Gomes, Dawn E Barkans, Deborah A Nebenzahl, Dennis G Kawabata, Dennis R Hudson, Devon M Shoop, Dianne B Latona, Dolores E Price, Don H Bark, PhD, Donald B Mckechnie, Dov H Pluznik, PhD, Edward D Mcdonald, Edwin Melendez, Eileen A Liu, Elizabeth S Howell, Farhana Khan, Gayle S Lawson, Gerard Pde Leon, Gloria J Baca, MS, Gordon T Wales, Heika R Bounds, Heika R Tait, Jacqueline Mdiaz Albertini, James C Henry, James D Hildreth, James S Cartwright, James S Stuart, BS, Jane M Kreis, Jean C Colon Lopez, Jeffrey J Leclair, Jennifer L Bridgewater, Jessica B Clark, Joey V Quitania, John Burr, John T Sproul, Jonathan T Little, Julia E Chervoni, Julian C Hanson, June H Wetherington, Kari M Johansen, Kathryn A Krentz, Keegan B Mixon, Kenneth O Gee, PhD, Kimberly Jproctor Jones, Kristin M Abaonza, Laurel A Beer, Lawrence Y Lee, PhD, LCDR Debra Emerson, Linda S Leja, Lisa A Bowden, Lisa K Capron, Lisa M Althar, Lori J Silverstein, Lorna F Jones, Lynda L Perry, PhD, Marcelo O Mangalindan, Jr, Margo C Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark W Babbitt, Maxine H Wong, Michael J Nerz, Michael S Hudson, Mihaly S Ligmond, Mikel T Wright, Nancy A Saxenian Emmons, Nancy E Byerly, Omotunde O Osunsanmi, Paul F Rader, Paul M Kawamoto, Paul Rader, Paula A Trost, Peter C Chow, Peter T Regan, Philip E Ake, Prabhu P Raju, Randy L Self, Rebecca A Sletner, Rebecca Rodriguez, Rebecca T Davis, Robert D Tollefsen, Roger F Zabinski, Rowena S Nguyen, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sara H Gabel, Scott A Nabe, Scott W Fox, Sharon I Gundersen, Sherri N Rohlf, MD, Stanley B Eugene, BS, BME, Stephanie A Jameson, Sunitha K Rajaram, PhD, Susan F Laska, MS, Susan T Hadman, Terri L Dodds, Thomas C Mclean, CFS, Thomas J Arista, Timothy D Evans, Tina S Roecklein, Tracy K Li, Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica L Bush, Virgilio F Pacio, CSO, Wayne D Stowell, Xiomara Copeland, Yvonne M Larsen, Yvonne M Sharkey

Astrida B Mattson's Documents

Publish Date Document Type Title
December, 2002 FDA 483 Response Immunex Corp. - Form 483R, 2003-01-06
September, 2006 EIR WCG IRB, Inc - EIR, 2006-09-01
July, 2002 EIR John P Lenihan Jr, Md - EIR, 2002-07-29
April, 2009 FDA 483 Risingsun Iodine Products Corp. - Form 483, 2009-04-10
June, 2000 FDA 483 B & C Laboratories Inc - Form 483, 2000-06-01
January, 2000 EIR Central Admixture Pharmacy Services - EIR, 2000-01-31
July, 2001 EIR Immunex Corp. - EIR, 2001-07-09
November, 2005 EIR Rich Nature Nutraceutical Laboratories, Inc. - EIR, 2005-11-04
November, 2000 FDA 483 Barlean's Organic Oils LLC - Form 483, 2000-11-09
January, 2005 FDA 483 Medical Endeavors for Missions - Form 483, 2005-01-25
January, 2002 EIR Jubilant HollisterStier LLC - EIR, 2002-01-10
December, 2002 FDA 483 Immunex Corp. - Form 483, 2002-12-18
January, 2001 EIR Brazg, Ronald L., MD - EIR, 2001-01-11
April, 2002 EIR Richard W. Grady, MD - EIR, 2002-04-19
September, 2000 FDA 483 Rich Distributing - Form 483, 2000-09-29
May, 2003 EIR OFD Biopharma, LLC - EIR, 2003-05-16
June, 2001 FDA 483 MDS Pharma Services - Form 483, 2001-06-13
January, 2002 FDA 483 Jubilant HollisterStier LLC - Form 483, 2002-01-10
July, 2001 FDA 483 Immunex Corporation - Form 483, 2001-07-09
January, 2002 FDA 483 Response Jubilant HollisterStier LLC - Form 483R, 2002-01-14
March, 2003 FDA 483 Aseptico Inc - Form 483, 2003-03-07
March, 2000 EIR Sievers, Eric L., M.D. - EIR, 2000-03-03
October, 2004 FDA 483 Cappseals Inc - Form 483, 2004-10-08
May, 2003 FDA 483 OFD Biopharma, LLC - Form 483, 2003-05-16
February, 2007 FDA 483 PhotoMedex, Inc. - Form 483, 2007-02-07
July, 2002 FDA 483 John P Lenihan Jr, Md - Form 483, 2002-07-29
May, 2003 FDA 483 Response OFD Biopharma, LLC - Form 483R, 2003-06-16
March, 2000 FDA 483 Sievers, Eric L., M.D. - Form 483, 2000-03-03
May, 2002 FDA 483 Medical Endeavors for Missions - Form 483, 2002-05-17
August, 2002 EIR Quorum Review Inc. - EIR, 2002-08-30
December, 2003 EIR BioEnergetics, Inc. - EIR, 2003-12-05
November, 2002 EIR Kean B. Lawlor, MD - EIR, 2002-11-20
April, 2004 FDA 483 Aseptico Inc - Form 483, 2004-04-28
April, 2003 EIR Pascal Company, Inc. - EIR, 2003-04-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more